US2003135041A1PendingUtilityA1
Synthesis of ceftiofur intermediate
Assignee: ORCHID CHEMICALS & PHARM LTDPriority: Jan 4, 2002Filed: Jan 4, 2002Published: Jul 17, 2003
Est. expiryJan 4, 2022(expired)· nominal 20-yr term from priority
C07D 501/00C07D 501/18
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides an improved process for the preparation of 7-amino-3-[2-(furylcarbonyl)thiomethyl]-3-cephem-4-carboxylic acid represented by formula (I) by the condensation of 7-amino cephalosporanic acid (7-ACA) represented by formula (II) with furyl-2-carbonylthiol represented by formula (III) using borontrifluoride as condensing agent in an organic solvent at a temperature range of 20°-50°C.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A process for preparation of 3-[2-(furylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid represented by formula (I),
the said process comprising the steps of condensing 7-aminocephalosporanic acid (II) with furyl-2-carbonylthiol (III) in the presence of borontrifluoride at 20-50° C. in an organic solvent and isolating the compound of formula (I)
2 . A process as claimed in claim 1 , wherein the condensation reaction is performed at a temperature range of 30°-35° C.
3 . A process as claimed in claim 1 , wherein the reaction mixture of condensation is poured into ice cold water, adjusting the pH of the solution to 3-4 with a base to precipitate the solid.
4 . A process as claimed in claim 3 , wherein the pH of the solution lies/is in the range of 3.45-3.55.
5 . A process as claimed in claim 2 , wherein the solid obtained by precipitation is washed with a mixture of water and organic solvent, drying the solid at a temperature range of 40°-45° C. under vacuum.
6 . A process as claimed in claim 1 , wherein furyl-2-carbonylthiol of formula (III) without isolating is used as its solution in an organic solvent selected from a group consisting of ethylacetate, methyl acetate, propyl acetate, dichloromethane, toluene, diethyl ether,di-isopropyl ether and/or mixture thereof.
7 . A process as claimed in claim 1 , wherein the organic solvent used in the condensation reaction is selected from a group consisting of ethylacetate, methyl acetate, propyl acetate, dichloromethane, toluene, diethyl ether, di-isopropyl ether, acetonitrile, acetic acid or mixture thereof, most preferably ethyl acetate.
8 . A process as claimed in claim 1 , wherein the condensing agent borontrifluoride is used in a gaseous form or its solution in an organic solvent selected from ethyl acetate, acetonitrile, methyl acetate, propyl acetate, dichloromethane, toluene, diethyl ether, di-isopropyl ether and/or mixture thereof, most preferably in gaseous form.
9 . A process as claimed in claim 1 , wherein 3-8 moles of borontrifluoride is used with respect to 7-aminocephalosporanic acid, the preferred molar ratio being 4.5:1.
10 . A process as claimed in claim 3 , wherein the base used is selected from a group consisting of ammonium hydroxide, sodium hydroxide, or sodium carbonate and most preferably ammonium hydroxide.
11 . A process as claimed in claim 5 , wherein the organic solvent used for washing the final product is selected from a group consisting of acetonitrile, ethylacetate, acetone, methyl acetate, propyl acetate, dichloromethane, toluene, diethyl ether,di-isopropyl ether and/or mixture thereof.Join the waitlist — get patent alerts
Track US2003135041A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.